Allucent has acquired 4 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms.
Allucent has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (100%).
2000 Centregreen Way Suite 300,
Cary, North Carolina
27513
United States,
(919) 361-2286
www.allucent.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-01-05 |
Pharm-Olam International · Life Science
Bracknell, United Kingdom · www.pharm-olam.com Pharm-Olam International is a multinational Contract Research Organization (CRO) offering comprehensive clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines, making clinical research as Easy As I, II, III, IV™. |
- | Merger |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
